158 related articles for article (PubMed ID: 38293680)
1. mRNA Expression and Methylation of the
Pádua JDB; Mariano CFA; Fabro AT; Lizarte Neto FS; Zuliani RL; Sares CTG; Dos Santos JS; Sankarankutty AK; Tirapelli DPDC; Silveira VDS; de Molfetta GA; Júnior WADS; Brunaldi MO
Biomark Insights; 2024; 19():11772719231225206. PubMed ID: 38293680
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of the Immunohistochemical Expression of RAD51 and BRCA2 in Gastric Adenocarcinoma.
Pádua JDB; Mariano CFA; Fabro AT; Tirapelli DPDC; Sankarankutty AK; Dos Santos JS; Brunaldi MO
J Histochem Cytochem; 2022 Mar; 70(3):199-210. PubMed ID: 34978208
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous ATM/BRCA1/RAD51 expression variations associated with prognostic factors in Iranian sporadic breast cancer patients.
Hallajian Z; Mahjoubi F; Nafissi N
Breast Cancer; 2017 Jul; 24(4):624-634. PubMed ID: 28058614
[TBL] [Abstract][Full Text] [Related]
4. Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells.
Yuan R; Fan S; Wang JA; Meng Q; Ma Y; Schreiber D; Goldberg ID; Rosen EM
Prostate; 1999 Jun; 40(1):37-49. PubMed ID: 10344722
[TBL] [Abstract][Full Text] [Related]
5. Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma.
Zhang ZZ; Liu YJ; Yin XL; Zhan P; Gu Y; Ni XZ
World J Gastroenterol; 2013 Mar; 19(12):1968-74. PubMed ID: 23569343
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumors.
Honrado E; Osorio A; Palacios J; Milne RL; Sánchez L; Díez O; Cazorla A; Syrjakoski K; Huntsman D; Heikkilä P; Lerma E; Kallioniemi A; Rivas C; Foulkes WD; Nevanlinna H; Benítez J
J Clin Oncol; 2005 Oct; 23(30):7503-11. PubMed ID: 16234517
[TBL] [Abstract][Full Text] [Related]
7. The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer.
Söderlund K; Skoog L; Fornander T; Askmalm MS
Radiother Oncol; 2007 Sep; 84(3):242-51. PubMed ID: 17707537
[TBL] [Abstract][Full Text] [Related]
8.
Suzuki M; Kasajima R; Yokose T; Shimizu E; Hatakeyama S; Yamaguchi K; Yokoyama K; Katayama K; Yamaguchi R; Furukawa Y; Miyano S; Imoto S; Shinozaki-Ushiku A; Ushiku T; Miyagi Y
Transl Lung Cancer Res; 2023 Aug; 12(8):1738-1751. PubMed ID: 37691868
[TBL] [Abstract][Full Text] [Related]
9. A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers.
Kadouri L; Kote-Jarai Z; Hubert A; Durocher F; Abeliovich D; Glaser B; Hamburger T; Eeles RA; Peretz T
Br J Cancer; 2004 May; 90(10):2002-5. PubMed ID: 15138485
[TBL] [Abstract][Full Text] [Related]
10. Expression of DNA Damage Response Proteins and Associations with Clinicopathologic Characteristics in Chinese Familial Breast Cancer Patients with
Zhu X; Tian T; Ruan M; Rao J; Yang W; Cai X; Sun M; Qin G; Zhao Z; Wu J; Shao Z; Shui R; Hu Z
J Breast Cancer; 2018 Sep; 21(3):297-305. PubMed ID: 30275858
[TBL] [Abstract][Full Text] [Related]
11. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies.
Gatei M; Zhou BB; Hobson K; Scott S; Young D; Khanna KK
J Biol Chem; 2001 May; 276(20):17276-80. PubMed ID: 11278964
[TBL] [Abstract][Full Text] [Related]
12.
Poh W; Dilley RL; Moliterno AR; Maciejewski JP; Pratz KW; McDevitt MA; Herman JG
Clin Cancer Res; 2019 Apr; 25(8):2513-2522. PubMed ID: 30692098
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
Vet Pathol; 2009 May; 46(3):416-22. PubMed ID: 19176491
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
15. Homologous Recombination Repair Factors Rad51 and BRCA1 Are Necessary for Productive Replication of Human Papillomavirus 31.
Chappell WH; Gautam D; Ok ST; Johnson BA; Anacker DC; Moody CA
J Virol; 2015 Dec; 90(5):2639-52. PubMed ID: 26699641
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers.
Kontorovich T; Cohen Y; Nir U; Friedman E
Breast Cancer Res Treat; 2009 Jul; 116(1):195-200. PubMed ID: 18642075
[TBL] [Abstract][Full Text] [Related]
17. Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas.
Swisher EM; Gonzalez RM; Taniguchi T; Garcia RL; Walsh T; Goff BA; Welcsh P
Mol Cancer; 2009 Jul; 8():48. PubMed ID: 19602291
[TBL] [Abstract][Full Text] [Related]
18. RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination.
Lok BH; Carley AC; Tchang B; Powell SN
Oncogene; 2013 Jul; 32(30):3552-8. PubMed ID: 22964643
[TBL] [Abstract][Full Text] [Related]
19. BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.
Yuan SS; Lee SY; Chen G; Song M; Tomlinson GE; Lee EY
Cancer Res; 1999 Aug; 59(15):3547-51. PubMed ID: 10446958
[TBL] [Abstract][Full Text] [Related]
20. Examination of ATM, BRCA1, and BRCA2 promoter methylation in patients with pancreatic cancer.
Zhou C; Porter N; Borges M; Gauthier C; Ferguson L; Huang B; Nanda N; He J; Laheru D; Hruban RH; Goggins M; Klein AP; Roberts NJ
Pancreatology; 2021 Aug; 21(5):938-941. PubMed ID: 33839031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
